2025 Indicators of Progress for the Life Sciences Sector
How will we recognize advancements in 2025?
The year ahead for the life sciences sector will be shaped by advances in science, R&D, marketplace dynamics, economics, and politics. In this research brief, the IQVIA Institute examines key indicators of progress, including industry reputation, research productivity, biotech funding, therapeutic innovation, patient access, and health policy.
These indicators are not intended as predictions for 2025 – but rather a series of explicit markers that will reflect progress over the next year.
- Restored growth for the emerging biopharma sector
- Greater trust in life sciences companies
- Reduction in out-of-pocket costs for patients
- Expanded patient access to healthcare services
Inclusive progress on the “making America healthy" agenda and much more...
Download the report.
